Effects of methylphenidate (Ritalin) on mammalian myocardial ultrastructure

T A Henderson1, V W Fischer

  • 1Department of Anatomy and Neurobiology, St. Louis University Medical Center, MO 63104, USA.

The American Journal of Cardiovascular Pathology
|January 1, 1995
PubMed

Insights

Methylphenidate (Ritalin) hydrochloride (MPH) exposure caused lamellated lesions in rat and mouse hearts. These cardiac changes were persistent, suggesting cumulative effects of MPH on the myocardium.

Area of Science:

  • Cardiovascular pathology
  • Pharmacology
  • Toxicology

Background:

  • Previous observations noted lamellated ultrastructural lesions in the myocardium of a patient treated with methylphenidate hydrochloride (MPH).
  • A potential causal link between MPH exposure and these cardiac membranous changes required investigation.

Purpose of the Study:

  • To determine if methylphenidate hydrochloride (MPH) causes myocardial lesions.
  • To investigate the pathogenetic mechanisms and persistence of MPH-induced cardiac changes.

Main Methods:

  • Rats and mice were injected with varying doses of MPH for different durations.
  • Myocardial ultrastructure was examined, and lesions were quantified using stereological techniques.
  • Myocardial tissue was stained for acid phosphatase and sarcoplasmic reticulum to explore pathogenetic mechanisms.

Main Results:

  • MPH induced non-membrane-bound membrane accumulations and lamellations in the myocardium.
  • These lesions stained positively for sarcoplasmic reticulum but not for acid phosphatase.
  • Lesions were focal, surrounded by normal tissue, and persisted for at least 12 weeks after MPH cessation.

Conclusions:

  • Methylphenidate hydrochloride (MPH) induces myocardial lesions characterized by lamellations.
  • These lesions appear to involve the sarcoplasmic reticulum and are persistent.
  • MPH may exert cumulative and long-lasting effects on the myocardium.

Related Concept Videos